In the final hour of Oklahoma’s 2025 legislative session, as the clock neared 11 p.m. on May 29, state legislators [...] …
Blog Posts
A key health policy staffer for U.S. Senate Health, Education, Labor and Pensions (HELP) Committee Chairman Bill Cassidy (R-La.) recently [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
For the third straight time in 2025, a federal audit has found a drug manufacturer overcharged covered entities for 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two drugmakers recently added new medications to the list of drugs subject to their respective 340B contract pharmacy restrictions—one of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A recent drug-industry-funded study attributes the 340B program’s recent growth to increased utilization—not rising drug prices. The May 21 study, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Novartis and Bristol Myers Squibb (BMS) are asking a federal appeals court to expedite their challenge to a recent ruling [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major group purchasing organization (GPO) recently urged a Washington D.C. federal court to reject the federal government’s defense of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
Across America, safety-net hospitals stand as a lifeline for millions. These institutions serve patients who often have nowhere else to turn — individuals who are uninsured, underinsured, or living in communities where healthcare access is limited.
For hospitals operating on razor-thin margins, the 340B
…
There’s a gap in economics research on the 340B program, and economists could enrich 340B stakeholders’ understanding of the program [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical giant Amgen recently announced it will exempt Tennessee providers from its contract pharmacy restrictions despite a carve out in [...] …